Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.
about
CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species.miR-503 suppresses the proliferation and metastasis of esophageal squamous cell carcinoma by triggering autophagy via PKA/mTOR signaling.How Tumor Cells Choose Between Epithelial-Mesenchymal Transition and Autophagy to Resist Stress-Therapeutic Implications.
P2860
Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Phase I study of a chloroquine ...... nresectable pancreatic cancer.
@en
type
label
Phase I study of a chloroquine ...... nresectable pancreatic cancer.
@en
prefLabel
Phase I study of a chloroquine ...... nresectable pancreatic cancer.
@en
P2093
P2860
P1476
Phase I study of a chloroquine ...... nresectable pancreatic cancer.
@en
P2093
Alexander Knuth
Helga Bachmann
Marina Tusup
Panagiotis Samaras
Roger von Moos
Steve Pascolo
Thi Dan Linh Nguyen-Kim
P2860
P2888
P356
10.1007/S00280-017-3446-Y
P577
2017-10-04T00:00:00Z
P6179
1092059439